Electromed makes the SmartVest airway clearance system, a home and hospital device for people with compromised lung function. ELMD reports earnings on Tue, Nov 10, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 26 | Lake Street | Maintained | Buy |
Whale Options Flow
90DNo whale options trades in ELMD in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ELMD is in one of them and how their past ELMD trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered ELMD in an article yet. Here's the latest on the wider market.
About Electromed
Electromed makes the SmartVest Airway Clearance System, a device that uses air pulses to loosen and move mucus out of the lungs for people with compromised lung function. The company is based in New Prague, Minnesota. Its products are prescribed by physicians and sold into the home health care market and to hospitals, with patients including people with bronchiectasis, cystic fibrosis and neuromuscular conditions. Electromed sells directly to patients and clinicians, handling referrals, insurance billing and home training.
- Headquarters
- New Prague, MN